Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - temsirolimus - concentrate for solution for infusion - temsirolimus 25 mg/ml - temsirolimus - temsirolimus - first line treatment of patients with advanced renal cell carcinoma.torisel is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma.

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - (drug product) temsirolimus - injection, solution, concentrate - 25.0mg/ml - (drug product) temsirolimus 25.0mg/ml

European Union - English - EMA (European Medicines Agency)

pfizer europe ma eeig - temsirolimus - carcinoma, renal cell; lymphoma, mantle-cell - antineoplastic agents - renal-cell carcinomatorisel is indicated for the first-line treatment of adult patients with advanced renal-cell carcinoma (rcc) who have at least three of six prognostic risk factors.mantle-cell lymphomatorisel is indicated for the treatment of adult patients with relapsed and / or refractory mantle-cell lymphoma (mcl).

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - temsirolimus - concentrate and solvent for solution for infusion - 30 milligram(s) - protein kinase inhibitors; temsirolimus